segunda-feira, 7 de junho de 2021

US approves first new Alzheimer's drug in almost two decades #breakingnews #breaking #worldhealines

U.S. regulators on Monday approved Biogen Inc's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.

from https://ift.tt/34Yad88

Sem comentários:

Enviar um comentário